Abzyme Therapeutics


Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms.

Industries

Employees

11-50

Links


Org chart

Hiep Tran
President & Chief Scientific Officer
Collapse
Alexander H. Taylor
Director, Pre-clinical Studies
Steve Manobianco
Director, Business Development
Andrew Phillips
Lab Manager / Research Scientist
Carla Campbell
R&D Scientist I


Offices